Brighton Jones’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
Brighton Jones's IMNM Position: Q3 2026 in Review
Brighton Jones increased its Immunome (IMNM) stake by 0.05% in Q3 2026, buying an estimated $124 and bringing the position to 10,550 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #1207.
Brighton Jones first reported a position in IMNM in Q1 2024 and has held it in 6 quarters since. The position peaked at $231K in Q1 2026. 163 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.
- Brighton Jones held 10,550 shares of Immunome worth $227K as of Q3 2026.
- Brighton Jones bought 5 Immunome shares in Q3 2026, an estimated $124.
- Immunome made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1207 holding.
- Brighton Jones first reported a position in Immunome in Q1 2024 and has held it in 6 quarters since.
- Brighton Jones's Immunome position peaked at $231K in Q1 2026.
- 163 funds tracked by Wall St. Rank held Immunome as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.